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Abstract
Background: High procedure volume and dedication to unicompartmental knee arthroplasty (UKA) has been
suggested to improve revision rates. This study aimed to quantify the annual hospital volume effect on revision risk
in Oxfordu nicompartmental knee arthroplasty in the Nordic countries.
Methods: 14,496 cases of cemented medial Oxford III UKA were identified in 126 hospitals in the four countries
included in the Nordic Arthroplasty Register Association (NARA) database from 2000 to 2012. Hospitals were divided
by quartiles into 4 annual procedure volume groups (≤11, 12-23, 24-43 and ≥44). The outcome was revision risk
after 2 and 10 years calculated using Kaplan Meier method. Multivariate Cox regression analysis was used to assess
the Hazard Ratio (HR) of any revision due to specific reasons with 95% confidence intervals (CI).
Results: The implant survival was 80% at 10 years in the volume group ≤11 procedures per year compared to 83%
in other volume groups. The HR adjusted for age category, sex, year of surgery and nation was 0.87 (95% CI: 0.76-0.
99, p = 0.036) for the group 12-23 procedures per year, 0.78 (95% CI: 0.68-0.91, p = 0.002) for the group 24-43
procedures per year and 0.82 (95% CI: 0.70-0.94, p = 0.006) for the group ≥44 procedures per year compared to the
low volume group. Log-rank test was p = 0.003. The risk of revision for unexplained pain was 40-50% higher in the
low compared with other volume groups.
Conclusion: Low volume hospitals performing ≤11 Oxford III UKAs per year were associated with an increased risk
of revision compared to higher volume hospitals, and unexplained pain as revision cause was more common in
low volume hospitals.
Keywords: Knee, Osteoarthritis, Arthroplasty, Unicompartmental, Procedure volume, Revision causes
Background
The Oxford unicompartmental knee arthroplasty (UKA)
has been investigated in numerous studies due to the de-
viant results comparing registry results to studies from
high volume centers and surgeons. Data from national
registries show a significantly higher revision rate for
both short and long term results for UKA than for total
knee arthroplasty (TKA) [1–5]. Other studies from high-
volume Oxford developing centers, however, show excel-
lent long-term results [6, 7]. The existing variability in
practice regarding indication and usage of UKA results
in low volumes in hospitals using strict criteria [8], and
higher volumes in hospitals offering UKA to patients
using less strict criteria [9]. The Nordic Arthroplasty
Register Association is a collaboration of arthroplasty
registers in Sweden, Denmark, Norway and Finland
established in 2007. The cooperation has produced a
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common defined set of variables agreed upon, enabling
analyses of larger statistical material [10]. This is an ad-
vantage especially for uncommon methods and proce-
dures, such as the UKA constituting only 11% of the
knee arthroplasties in the Nordic countries [11]. The ad-
vantage of a registry study for our purpose was the rep-
resentation of all surgeons in all hospitals in Sweden,
Denmark, Finland and Norway resulting in more
generalizable findings. The UKA is utilized at similar
lower percentage than TKA in the majority of countries
with registries worldwide for the treatment of osteoarth-
ritis [2, 12]. The aim of this study was to investigate how
the patient risk for revision surgery after Oxford III
UKA varied as a function of hospital procedure volume.
Adding to the analyses for all causes of revision, the sec-
ond objective was to assess any differences in the pro-
portion of the specific causes of revision according to
volume groups.
Methods
Data sources
We used the NARA database, containing a common de-
fined code set to identify patients undergoing primary
cemented medial Oxford III UKA between January 1,
2000 and December 31, 2012 in this population-based
register study [11, 13]. Every year all uniform variables
from each national register are re-coded according to
common definitions and anonymized and then merged
into the NARA database. The linkage between primary
procedure and subsequent revision or death on individ-
ual data is performed in each national register before
merged into the NARA database. The first studies fo-
cused on differences in patient demographics, surgical
methods and implant brands [10, 11, 14]. The main pur-
pose of NARA was the ability to analyze a larger statis-
tical material, which is an advantage especially for
uncommon methods and implants. It reflects the current
practice in 4 different countries. The knee dataset cur-
rently includes 390,525 primary knee arthroplasty opera-
tions performed during 1995-2012 [13]. The Oxford
UKA was the most commonly registered UKA implant
in the NARA.
Study population
Implant brand and type could be a source of confound-
ing in comparison to revision rate according to hospital,
and therefore all other brands and types than Oxford III
UKA were excluded. Diagnoses other than osteoarthritis
(OA) were excluded as inflammatory disease is a contra-
indication in UKA. The inclusion criteria for this study,
to obtain comparable groups for analysis, are shown in
the flowchart (Fig. 1). In NARA revision is defined as re-
moval/exchange/addition of one or more implant
component(s) and is linked to the primary procedure by
the unique national identification number of the patient.
We identified 4211 (29.0%) Oxford III implants in
Denmark in 32 different hospitals: 2218 (15.3%) in
Sweden distributed among 18 hospitals, 3910 (27.0%) in
Finland in 41 hospitals and 4157 (28.7%) in Norway in
35 hospitals (Table 1). The inclusion of bilateral knee
arthroplasty can be a violation of the assumption of in-
dependent observations in survival analyses, but studies
have shown that the effect is minor regarding statistical
precision for survival analysis of knee replacements [15].
In this study, 14% of the patients had bilateral knee
arthroplasty.
Exposure
All Oxford III UKA procedures were entered into one of
four different annual hospital volume groups. We used
quartiles to divide into equal numbered volume groups;
≤11, 12-23, 24-43 and ≥44 procedures per year. Hospi-
tals with inconsistent procedure volume over time may
have contributed to different volume groups according
to the number of procedures at their hospital in the year
of surgery. Thus, for each hospital each year was exam-
ined individually. This categorization of the exposure as-
sumes that unspecified hospital-level effects are trumped
by a potential volume effect on revision rates. Revision
due to any reason as well as specific causes for revision
was analysed.
Statistics
Survival analyses were performed with any revision of
the implant as endpoint. Kaplan Meier cumulative sur-
vival at 2 and 10 years was reported. A 2 year follow-up
was chosen to assess early revisions. The follow-up
started at the day of primary UKA procedure and ended
at the day of first revision, death, emigration or the end
of follow-up time (December 31st 2012). The two high-
est volume groups had shorter follow-up compared to
the lower (chi-square test p-value <0.001). Log-rank test
was performed, p = 0.003. Differences for categorical
variables such as sex, age categories, year of surgery and
nations were assessed by Pearson’s chi-squared test. Any
p-values less than 0.05 were considered significant. To
estimate differences in continuous variables the student
t-test was used.
The Cox regression model was used to calculate Haz-
ard Ratios (HR) with 95% confidence interval (CI) for
the 10 year follow-up period to investigate the associ-
ation between four hospital procedure volume groups
and implant survival time. P-values were presented rela-
tive to the lowest volume group (≤ 11). All p-values less
than 0.05 were considered to be statistically significant.
The Cox model included sex, age category, year of sur-
gery, nation and hospital volume. Death is to be
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considered a possible competing risk to revision. We
studied the influence of death by performing a compet-
ing risk analysis using the statistical software R [16, 17].
The results for the volume groups did not change sig-
nificantly when accounting for death as a competing risk
for revision (Table 2). Cox regression analyses were
made for the different confounding variables and are
presented in Table 3.
The various reasons for revision were organized hier-
archically with infection first and unexplained pain last,
as shown in Table 4. Loosening and wear were second in
the list and instability and dislocation third. The group
‘other reasons’ contained new diseases occurring in the
joint such as osteoarthritis or osteonecrosis laterally or
joint fibrosis with stiffness. Surgical errors such as incor-
rect sizing of components were also included in this
group. When more than one reason was reported, the
top reason in the hierarchy was used as endpoint in the
analyses. Pain as a cause of revision was used as
endpoint only when pain was the only reason reported.
HR with 95% CI was reported for different revision
causes with 10 years follow-up. The proportional haz-
ards assumption of the Cox model was tested based on
log-minus-log plot and found to be valid. SPSS version
23 and R statistical software package version 3.2.1 were
used for the statistical analyses.
Results
126 hospitals performed 14,496 cemented medial Oxford
III UKA from 2000 to 2012 in the 4 Nordic countries.
Demographics and patient characteristics are shown in
Table 1. The median number of procedures performed
annually by a hospital was 23 (IQR (inter quartile range)
=12-44). The median annual procedure volume per hos-
pital in Denmark was 41 (IQR = 23-61), 27 (IQR = 13-
48) in Sweden, 18 (IQR = 9-36) in Finland and 17
(IQR = 10-26) in Norway. The most common annual
hospital volume was 1 per year, the second and third
Fig. 1 14,496 cemented medial Oxford III UKA from 2000 to 2012 were selected for inclusion in this study. Other diagnoses than osteoarthritis
were excluded. Abbreviations: NARA = Nordic Arthroplasty Register Association, OA = osteoarthritis
Badawy et al. BMC Musculoskeletal Disorders  (2017) 18:388 Page 3 of 8
most common annual procedure volume was 2 and 3
per year respectively.
The Kaplan Meier 2 year survival was 95% for the three
hospitals groups with annual procedure volume > 11 and
93% for the hospitals performing ≤11 Oxford III UKA per
year. The Kaplan Meier estimated survival had dropped to
80% at 10 years follow up with poorest result for the ≤11
per year group (Table 2). The three hospital volume groups
of >11 had an estimated survival of 83% at 10 years. The
Log-rank test was statistically significant with p = 0.003.
In the Cox regression model, the high volume groups
(≥44 procedures per year) had a lower risk of any revision
during the entire follow-up time of 10 years compared
with the lowest volume group (≤ 11 procedures per year)
according to adjusted HR = 0.82 (95% CI 0.70-0.94,
p = 0.006). Similarly, the adjusted HRs were 0.78 (95% CI
0.68-0.91, p = 0.002) for the group performing 24-43 pro-
cedures per year and 0.87 (95% CI 0.76-0.99, p = 0.036)
for the group performing 12-23 procedures per year com-
pared to the lowest volume group (Table 2, Fig. 2).
Table 1 Patient and procedure characteristics of 14,496 cemented medial Oxford III unicompartmental knee arthroplasty according
to four hospital volume categories with the diagnosis osteoarthritis from 2000 to 2012
Annual hospital volume groups
≤11 12-23 24-43 ≥44
p-values
No of procedures 3528 3759 3533 3676
Men % 42 43 44 44 0.17
Agemedian (range) 62 (28-94) 63 (34-93) 65 (33-94) 65 (33-95)
Age group n (%)
<55 731 (21) 652 (17) 501 (14) 540 (15) <0.001
55-64 1471 (42) 1469 (39) 1199 (34) 1339 (36)
65-74 946 (27) 1169 (31) 1251 (35) 1240 (34)
≥75 380 (11) 469 (13) 582 (17) 566 (15)
Year of surgery
2000-03 962 (27) 826 (22) 399 (11) 475 (13) <0.001
2004-06 928 (26) 1061 (28) 562 (16) 1113 (30)
2007-09 925 (26) 1281 (32) 1349 (38) 900 (25)
2010-12 713 (20) 654 (18) 1223 (35) 1188 (32)
Nation n (%)
Denmark (4211) 558 (16) 615 (16) 1118 (32) 1920 (52) <0.001
Norway (4157) 1273 (36) 1551 (41) 1147 (33) 186 (5)
Sweden (2218) 460 (13) 561 (15) 508 (14) 689 (19)
Finland (3920) 1237 (35) 1032 (28) 760 (21) 881 (24)
Table 2 Results from survival and Cox regression analyses on hospital volume for 14,496 cemented medial Oxford III
unicompartmental knee arthroplasty in NARA 2000-2012
Annual hospital
volume groups
Number of
procedures
Number of
revisions (%)
Number of
deathsa (%)
K-M 2-year
survival
(95%CI)
K-M 10-year
survival
(95%CI)
Cox Regression
Unadjusted
HR(95%CI)
10 years
p-
value
Cox Regression
Adjusted RR(95%CI)
10 years
p-
value
≤11 3528 481 (13.6) 231 (6.5) 93 (92.4-94.0) 80 (78.0-82.0) 1.0 (ref) 1.0 (ref)
12-23 3759 429 (11.4) 237 (6.3) 95 (94.1-95.7) 83 (80.8-84.4) 0.85 (0.75-0.97) 0.017 0.87 (0.76-0.99) 0.036
24-43 3533 293 (8.3) 185 (5.2) 95 (94.1-95.7) 83 (80.2-86.2) 0.78 (0.67-0.90) 0.001 0.78 (0.68-0.91) 0.002
≥44 3676 351 (9.5) 227 (6.2) 95 (94.3-95.9) 83 (80.7-85.5) 0.82 (0.72-0.95) 0.006 0.82 (0.70-0.94) 0.006
K-M Kaplan-Meier estimated cumulative survival at 2 and 10 years (%)
HR Hazard Ratio; with adjustment for age category, sex, year of surgery and nation
CI confidence interval
Ref reference
aNo statistical significant differences in proportion of deaths within the groups, p-value equal to 0.11
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In the multivariable survival model we found inferior
results for the youngest age group <55 with Hazard Ra-
tio HR = 1.29 (95% CI 1.13-1.47, p = <0.001) with 55-64
as reference. The ≥75 age group showed better results;
HR = 0.65 (95% CI 0.55-0.78, p < 0.001) (Table 3, Table
5). Gender was not found to influence the results. There
seems to be a deterioration in results in the more recent
years of surgery (HR = 1.33 (95%CI 1.10-1.62)).
Denmark had statistically significant higher relative risk
(HR = 1.41 (95%CI 1.19-1.68, p < 0.001)) compared to
Sweden as reference. Similarly, Norway had HR = 1.24
(95%CI 1.05-1.47, p = 0.01). Finland had HR = 1.18
(95%CI 1.00-1.39, p = 0.05) (Table 3).
Revision causes
The distribution of revision causes among the 1519 re-
vised cemented medial Oxford III implants from 2000 to
2012—according to hospital volume—is shown in Table
4. We found a difference in the risk of revision for unex-
plained pain among the volume groups. The volume
groups performing >11 Oxford III UKA per year revised
40-50% fewer patients for unexplained pain than the
lowest volume hospitals (≤11 per year). The other revi-
sion causes did not show any statistically significant dif-
ferences between the groups (Table 4).
Discussion
In this large population based study based on 14,496
cemented medial Oxford III unicompartmental knee
arthroplasty performed in four Scandinavian countries; we
showed that high procedure volumes (>11 procedures per
year) were associated with a decreased risk for revision.
This study contributes to the knowledge of other pre-
viously published results. There are available studies on
the impact of procedure volume in UKA, and the com-
mon denominator is the Oxford implant since its usage
is widespread. The Swedish study from 2001 found that
performing less than 23 UKA per year was associated
with a higher risk of revision [18], whereas Baker et al.
[19] suggested a minimum annual volume of 13. Our
previous study from Norway indicated fewer revisions
Table 3 Cox proportional survival model with Hazard Ratios
(HR) adjusted for age, sex, year of surgery and nation as
covariates with 95% CI (confidence interval) for all reasons for
revision up to 10 years after primary surgery
Variables No of procedures HR(95%CI) p-value
Age group
55-64 5469 1.0 (ref)
< 55 2424 1.3 (1.1-1.5) <0.001
65-74 4606 0.8 (0.7-0.9) <0.001
≥ 75 1997 0.7 (0.6-0.8) <0.001
Sex
Male 6272 1.0 (ref)
Female 8224 1.0 (0.9-1.1) 0.6
Year of surgery
2000-03 2662 1.0 (ref)
2004-06 3664 1.2 (1.0-1.3) 0.04
2007-09 4392 1.2 (1.0-1.4) 0.02
2010-12 3778 1.3 (1.1-1.6) 0.004
Nation
Sweden 2218 1.0 (ref)
Denmark 4211 1.4 (1.2-1.7) <0.001
Norway 4157 1.2 (1.0-1.5) 0.01
Finland 3910 1.2 (1.0-1.4) 0.05
Table 4 Revisions causes with 10 years follow up. Hazard Ratios with confidence intervals for different hospital volumes, adjusted for
sex, age category, year of surgery and nation
Annual
hospital
volume
group
Number of
procedures
Number
of
revisions
Revision causes with adjusted Hazard Ratios (95% confidence interval)
Infection Loosening/Wear Instability/Dislocation Unexplained pain Other reasons Unknown reasons
1519 n = 57 n = 545 n = 104 n = 273 n = 498 n = 42
≤11 3528 465 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
12-23 3759 420 1.02 (0.49-2.16) 1.04 (0.83-1.29) 1.66 (1.00-2.76) 0.54 (0.39-0.75) 0.72 (0.57-0.91) 1.90 (0.83-4.39)
24-43 3533 292 0.92 (0.41-2.02) 0.80 (0.61-1.04) 1.12 (0.61-2.05) 0.64 (0.46-0.89) 0.80 (0.62-1.04) 1.12 (0.44-2.86)
≥44 3676 342 1.20 (0.54-2.64) 0.93 (0.73-1.19) 1.15 (0.58-2.28) 0.56 (0.39-0.80) 0.77 (0.60-0.99) 0.47 (0.14-1.51)
Number of revisions in each volume group:
≤11 13 157 23 96 168 8
12-23 15 166 43 60 118 18
24-43 13 93 21 61 93 11
≥44 16 129 17 56 119 5
n numbers
ref reference
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with an annual caseload of more than 40 [20]. A study
from the National Joint Registry of England and Wales
(NJR) regarding determinants of revision following UKA
supported the importance of experience measured at the
unit level as well, and also favoring consultants rather
than trainees [21]. A recent study from the NJR recom-
mended surgeons to perform at least 20% of their knee
arthroplasties as UKAs to achieve lower rates of revi-
sions [22]. They also found that 81.4% of the surgeons
performed less than 10 UKA per year. This corresponds
to our findings of extreme skewness with dominance of
low-volume performance. Some registers on the other
hand recommend the use of fewer UKA due to higher
failure rates [23]. Our study from 4 countries suggests a
minimum hospital volume per hospital of 11. However,
considering the variety of the previously mentioned
studies and results, a threshold value of 11 per year
could be considered a conservative value.
Our study included data from 4 different national regis-
ters with multiple surgeons and hospitals with varying ex-
perience and volume, suggesting high external validity. It
reflects the practice in 4 different countries. Due to
complete follow up of all patients in the study population
with censoring at the time of death, emigration, or at the
end of follow up, selection bias is unlikely. Additionally,
only patients who received an Oxford III UKA with the
diagnosis OA were selected (Fig. 1). We limited the ana-
lyses to the latest time period from 2000, excluding older
implants and techniques. Using previously described
methods of analysing the impact of procedure volume also
strengthen the study [20, 22, 24, 25]. The advantage of ana-
lyzing each year separately is the reflection of the procedure
volume that particular year.
Revision was less likely in older patients compared to
the younger in our study. Other studies have shown that
young patients experience an increased risk of revision
after UKA compared to older patients [21, 26–28]. W-
Dahl et al. [29] and Liddle et al. [21] also found that
older patients had the greatest benefits and the lowest
revision rates. In addition, UKA has been associated
with lower rates of morbidity and mortality compared to
TKA [30]. Sweden had the best implant survival of all
the 4 countries. This could be a result of longer training
of Swedish surgeons, starting unicompartmental knee
arthroplasty surgery and a knee arthroplasty register before
the other Nordic countries, and thereby gaining more ex-
perience. Sweden differs from the other nations with less
than 50% of the implanted UKAs being Oxford and thus
their learning curve could be improved by surgical experi-
ence performing other types of UKA. Denmark had inferior
results compared to the other countries and contributed to
the majority of patients in high volume hospitals (52% in the
≥44 group). We performed sensitivity analysis with and
without data from Denmark. The tendency in the results for
the volume groups did not change excluding Denmark.
Denmark also has poorer results in the low volume
groups. The cause of poorer results in Denmark is not
possible to verify, but learning curve, threshold for
Fig. 2 Cox regression survival curve adjusted for age, sex, year of
surgery and nation
Table 5 Results from Kaplan Meier 10 year survival analysis for age as stratification variable according to volume groups with 95%
confidence interval
Age groups
Annual Hospital Volume < 55 yrs.
n = 2424
55-64
n = 5469
65-74
n = 4606
≥75
n = 1997
For all ages (table 2)
n = 14,496
≤11 74 (69.4-78.2) 79 (76.4-82.4) 82 (78.7-85.9) 89 (84.2-94.2) 80 (78.0-82.0)
12-23 74 (67.3-79.7) 81 (78.1-84.1) 87 (84.4-90.0) 87 (82.0-91.2) 83 (80.8-84.4)
24-43 77 (68.8-84.6) 83 (77.5-87.5) 84 (78.7-88.7) 90 (85.5-93.5) 83 (80.2-86.2)
≥44 79 (69.8-88.2) 81 (77.6-85.2) 84 (79.3-88.5) 90 (86.5-92.9) 83 (80.7-85.5)
n numbers
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revision and patient selection could be explanation factors.
Theoretically, an increase in inexperienced surgeons
implementing a new technique could initially lead to
many revisions, but if continued, an expected improve-
ment should occur. This could also explain the deteriorat-
ing results in the last time period.
Analyses of specific revision causes revealed a higher
risk of revision for unexplained pain in low volume hos-
pitals as compared to higher volume hospitals. We
found minor differences for the other revision causes
(Table 4). Baker et al. found that while more unicom-
partmental knee implants than total knee implants were
revised for unexplained pain, when these revisions for
unexplained pain were discounted, unicompartmental
knee arthroplasty still had a significantly greater risk of
revision from other reasons than did total knee arthro-
plasty [31]. However the numbers of revisions in each
group were too small to allow making any conclusions
regarding the differences between the volume groups.
There has been an on-going discussion regarding the
threshold for revision due to unexplained pain [32]. Simi-
larly, the incidence of radiolucent lines at the bone-implant
interface [33] could be misinterpreted as loosening by unex-
perienced Oxford-users, and thereby leading to unnecessary
revisions. Nevertheless, in cases with concurrent pain or
symptomatology, it could be argued that revision is moti-
vated. These could be explanations to the differences in revi-
sion rates, suggesting a lower revision-threshold in low-
volume users. However, even the highest volume hospitals
could not match the outcomes reported by developers [6, 7,
34] or the results after TKA regarding revision rates [24,
35]. A retrospective independent sample of failures reported
to the registers could be one approach to evaluate the indi-
cation for revision surgery and identifying critical errors in
the primary surgical technique and patient selection. Precise
surgical indications for both primary and revision surgery
are still debated [8, 22]. Furthermore, whether emphasis
should be put on the higher revision rates of UKA com-
pared to TKA or the lower risk of postoperative death and
complications comparing UKA to TKA is also important to
take into consideration [35].
Limitations to the study may be unmeasured factors such
as decision-making regarding pre-operative radiographic
changes leading to primary indication for surgery [36]. In
addition, information on life style factors and physical activ-
ity was not available. The selection of patients considered
suitable for UKA surgery is debatable regarding radiographic
findings, age and BMI [8, 22]. Only hospital procedure vol-
ume was available for analysis in the NARA database, sur-
geon caseload and experience were not available.
Theoretically, a high volume surgeon in a high volume cen-
ter would gain the best results according to a systematic re-
view regarding surgery volume [37]. However, the volume of
a center had an equal if not greater effect on patient
outcome than surgeon volume. Categorization of the vol-
ume exposure assumes that any (unspecified) hospital-level
effects (e.g. the care that patients within a specific hospital
receive, independent of volume) are trumped by a potential
volume effect on revision rates. The analyses in this study
are limited to the cemented medial Oxford III UKA and
may limit the generalizability of the results to be valid for
other UKA implant types.
Conclusion
Hospitals performing ≤11 Oxford III UKA per year had
a higher risk of revision, and were more likely to per-
form revisions due to unexplained pain.
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